Provided by Tiger Trade Technology Pte. Ltd.

AQR Capital Holdings

2,708.99
+23.560.88%
Number of Gainers:57
Number of Losers:39
Number of Flat:2
PE:- -
High:2,717.52
Open:2,685.39
Low:2,685.39
Close:2,685.43
Volume:1.14B
Turnover:222.75B
Market Cap:49.54T
Float Cap:46.10T

Loading ...

Microsoft is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Sep 21

Goldman Sachs Raises Alstom Stake to 5.82%

Reuters
·
Sep 21

Einride Shares Climb After Partnering with Nvidia

Dow Jones
·
Sep 21

Einride Collaborates With Nvidia to Expand Freight Network of Autonomous Operations

MT Newswires Live
·
Sep 21

Market Chatter: Tesla's Racial Discrimination Trial in California Begins Today

MT Newswires Live
·
Sep 21

Old Dominion announces general rate increase of 4.9%

TIPRANKS
·
Sep 21

Anterix announces new iPhone 18 Pro, Duo use Anterix 900 MHz spectrum

TIPRANKS
·
Sep 21

BlackRock American Income Trust NAV at 275.79p Including Current Year Income, 275.3p Capital-Only

Reuters
·
Sep 21

Options Volatility and Implied Earnings Moves This Week, September 22 – September 24, 2026

TIPRANKS
·
Sep 21

Old Dominion Freight Line, - Announces 4.9% General Rate Increase Effective October 5, 2026

THOMSON REUTERS
·
Sep 21

Old Dominion Freight Line, Inc. Announces General Rate Increase

THOMSON REUTERS
·
Sep 21

Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab

GlobeNewswire
·
Sep 21

Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing

THOMSON REUTERS
·
Sep 21

Analysts Offer Insights on Consumer Cyclical Companies: Nike (NKE) and Gentherm (THRM)

TIPRANKS
·
Sep 21

Analysts Are Bullish on These NA Stocks: BlossomHill Therapeutics, Inc. (BLSM), Micron (MU)

TIPRANKS
·
Sep 21

Japan Health Ministry Approves Merck’s Keytruda QLEX for Subcutaneous Use Across Keytruda Indications

Reuters
·
Sep 21

Nike price target lowered to $40 from $45 at Stifel

TIPRANKS
·
Sep 21

Merck’s Keytruda Qlex™ (Pembrolizumab and Berahyaluronidase Alfa-Pmph) Approved in Japan for Subcutaneous Administration for All Keytruda® (Pembrolizumab) Indications Approved in Japan

THOMSON REUTERS
·
Sep 21

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Reuters
·
Sep 21

HP Expecting Industry-Wide PC Volumes to Decline in 2027

Dow Jones
·
Sep 21